EFFECTS OF 3 GENETIC-LOCI IN A PEDIGREE WITH MULTIPLE LIPOPROTEIN PHENOTYPES

被引:28
作者
EMI, M
HEGELE, RM
HOPKINS, PN
WU, LL
PLAETKE, R
WILLIAMS, RR
LALOUEL, JM
机构
[1] UNIV UTAH,HLTH SCI CTR,HOWARD HUGHES MED INST,ECCLES INST HUMAN GENET,SUITE 6200,SALT LAKE CITY,UT 84112
[2] UNIV UTAH,CARDIOVASC GENET RES CLIN,SALT LAKE CITY,UT 84112
来源
ARTERIOSCLEROSIS AND THROMBOSIS | 1991年 / 11卷 / 05期
关键词
LINKAGE ANALYSIS; TYPE-IIA HYPERLIPOPROTEINEMIA; LOW DENSITY LIPOPROTEIN RECEPTOR DEFECT; PEDIGREE ANALYSIS;
D O I
10.1161/01.ATV.11.5.1349
中图分类号
R5 [内科学];
学科分类号
1002 ; 100201 ;
摘要
In the course of familial investigations of coronary artery disease, we identified an extended kinship in which several members were affected with type IIa hyperlipoproteinemia (HLPIIa), type III dyslipoproteinemia (DLPIII), or hypobetalipoproteinemia (HBLP). To study the genetic defects responsible for plasma lipoprotein abnormalities in this pedigree and to investigate the phenotypic effect of different genotypic combinations, we used molecular markers for apolipoprotein (apo) B, apo E, and the low density lipoprotein (LDL) receptor to characterize segregation at each locus. Linkage analysis showed that elevated LDL cholesterol levels and the HBLP phenotype were due to defects at the LDL receptor and the apo B loci, respectively. One pedigree member, who inherited both an LDL receptor allele linked with elevated LDL cholesterol levels and an apo B allele linked with HBLP, had a normal lipoprotein phenotype. Seven patients who simultaneously inherited the defective LDL receptor allele and one or two apo E2 alleles manifested DLPIII. The E2 alleles in this pedigree were shown by DNA sequence analysis to be the common E2 158(arginine --> cysteine) allele. These findings suggested a possible interaction between the abnormal LDL receptor and apo E2 alleles, resulting in the expression of DLPIII in the presence of a single copy of apo E2.
引用
收藏
页码:1349 / 1355
页数:7
相关论文
共 31 条
[11]  
HAZZARD WR, 1981, LANCET, V1, P298
[12]   RFLPS UPSTREAM OF THE LOW-DENSITY LIPOPROTEIN RECEPTOR (LDLR) GENE [J].
HEGELE, RA ;
EMI, M ;
NAKAMURA, Y ;
LALOUEL, JM ;
WHITE, R .
NUCLEIC ACIDS RESEARCH, 1988, 16 (14) :7214-7214
[13]  
HERBERT PN, 1983, METABOLIC BASIS INHE, P587
[14]   TYPE-III DYSLIPOPROTEINEMIA IN PATIENTS HETEROZYGOUS FOR FAMILIAL HYPERCHOLESTEROLEMIA AND APOLIPOPROTEIN-E2 - EVIDENCE FOR A GENE GENE INTERACTION [J].
HOPKINS, PN ;
WU, LL ;
SCHUMACHER, MC ;
EMI, M ;
HEGELE, RM ;
HUNT, SC ;
LALOUEL, JM ;
WILLIAMS, RR .
ARTERIOSCLEROSIS AND THROMBOSIS, 1991, 11 (05) :1137-1146
[15]  
INNERARITY TL, 1984, J BIOL CHEM, V259, P7261
[16]   A RFLP ASSOCIATED WITH THE LOW-DENSITY-LIPOPROTEIN RECEPTOR GENE (LDLR) [J].
KOTZE, MJ ;
LANGENHOVEN, E ;
DIETZSCH, E ;
RETIEF, AE .
NUCLEIC ACIDS RESEARCH, 1987, 15 (01) :376-376
[17]  
LASSER N L, 1972, Clinical Research, V20, P549
[18]   STRATEGIES FOR MULTILOCUS LINKAGE ANALYSIS IN HUMANS [J].
LATHROP, GM ;
LALOUEL, JM ;
JULIER, C ;
OTT, J .
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA-BIOLOGICAL SCIENCES, 1984, 81 (11) :3443-3446
[19]   INFERENCE OF A MOLECULAR DEFECT OF APOLIPOPROTEIN-B IN HYPOBETALIPOPROTEINEMIA BY LINKAGE ANALYSIS IN A LARGE KINDRED [J].
LEPPERT, M ;
BRESLOW, JL ;
WU, L ;
HASSTEDT, S ;
OCONNELL, P ;
LATHROP, M ;
WILLIAMS, RR ;
WHITE, R ;
LALOUEL, JM .
JOURNAL OF CLINICAL INVESTIGATION, 1988, 82 (03) :847-851
[20]  
Mahley Jr RWRS, 1989, METABOLIC BASIS INHE, P1195